![Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity - eBioMedicine Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity - eBioMedicine](https://www.thelancet.com/cms/attachment/3b8ed59a-e551-4e3c-a93d-a4d68a9e7052/gr1_lrg.jpg)
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity - eBioMedicine
![Cancers | Free Full-Text | Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer Cancers | Free Full-Text | Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer](https://www.mdpi.com/cancers/cancers-13-05748/article_deploy/html/images/cancers-13-05748-g001.png)
Cancers | Free Full-Text | Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer
![Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies - ScienceDirect Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2001037018303301-gr1.jpg)
Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies - ScienceDirect
![Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC](https://journals.sagepub.com/cms/10.1177/1073274818789357/asset/images/large/10.1177_1073274818789357-fig1.jpeg)
Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC
![Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia | Scientific Reports Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-25310-1/MediaObjects/41598_2018_25310_Fig1_HTML.jpg)
Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia | Scientific Reports
![Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis | Scientific Reports Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-68835-0/MediaObjects/41598_2020_68835_Fig1_HTML.png)
Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis | Scientific Reports
![First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/31/12/4417/F1.large.jpg)
First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research
![Frontiers | Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry Frontiers | Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry](https://www.frontiersin.org/files/Articles/665595/fonc-11-665595-HTML/image_m/fonc-11-665595-g001.jpg)
Frontiers | Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry
![Noninvasive Point-of-Care Nanobiosensing of Cervical Cancer as an Auxiliary to Pap-Smear Test | ACS Applied Bio Materials Noninvasive Point-of-Care Nanobiosensing of Cervical Cancer as an Auxiliary to Pap-Smear Test | ACS Applied Bio Materials](https://pubs.acs.org/cms/10.1021/acsabm.1c00470/asset/images/large/mt1c00470_0015.jpeg)
Noninvasive Point-of-Care Nanobiosensing of Cervical Cancer as an Auxiliary to Pap-Smear Test | ACS Applied Bio Materials
![Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives: Molecular Therapy - Oncolytics Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/26260aab-eb79-4e73-9885-c1fe33d73c04/fx1_lrg.jpg)
Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives: Molecular Therapy - Oncolytics
![Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer - ScienceDirect Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1934590921001181-fx1.jpg)
Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer - ScienceDirect
![Tumor Marker Score for Prognostication of Early-stage Squamous Cell Cervical Cancer | Anticancer Research Tumor Marker Score for Prognostication of Early-stage Squamous Cell Cervical Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/34/2/887/T1.medium.gif)
Tumor Marker Score for Prognostication of Early-stage Squamous Cell Cervical Cancer | Anticancer Research
![Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer - eBioMedicine Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer - eBioMedicine](https://www.thelancet.com/cms/attachment/e762d271-ef36-41a4-9336-98225f082247/gr1_lrg.jpg)